Both Korian and Orpea’s share prices increased more than 10% after the release of investigative TV show Cash Investigation’s hidden camera episode revealing scenes inside a Korian nursing home. Meanwhile Orpea’s expansion into Russia has been halted after last week’s invasion of Ukraine and French public investment bank Bpifrance pulled out.
How are for-profit health care groups being affected by and reacting to the Russian invasion of Ukraine? Some are providing free services to refugees, others are supporting Ukrainian armed forces. HBI speaks to Michał Rybak, CFO at Lux Med, leading Polish for-profit operator and Konstantin Lebediev, an expert on private healthcare in Ukraine and a former General Manager of the first private hospital in Central and Eastern Europe (CEE).
The eyes of the world have been on Ukraine recently, as the risk of a Russian invasion ramps up. HBI speaks to operators, private equity, and pharma in the region to see if nerves are being held, or fraying, and how what happens in the next few weeks might hit for-profit healthcare in the region.
Russian hospital operator EMC will go public at a 2020 EBITDA/enterprise value ratio of 11x after the group set its pricing at the bottom of the indicative range. The group has also revealed that Igor Shilov will remain the majority shareholder.